Asymmetric cortical degeneration syndromes

Current Opinion in Neurology

Volumn 9, Issue 4, 1996, Pages 276-280

  Caselli, Richard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHASIA; BRAIN ASYMMETRY; BRAIN CORTEX ATROPHY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE CLASSIFICATION; FRONTAL LOBE; HUMAN; MOTOR PERFORMANCE; REVIEW;

EID: 0029779764     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199608000-00006     Document Type: Review

References (42)

1. Caselli RJ: Focal and asymmetric cortical degeneration syndromes. Neurologist 1995, 1:1-19. A comprehensive review of this topic with details of a classification scheme.
2. Wilhelmsen KC, Lynch T, Nygaard TG: Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994, 55:1159-1165.
3. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AAF, Keohane C, Nygaard TG, Fahn S et al: Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 1994, 44:1878-1884.
4. Petersen RB, Tabaton M, Chen SG, Monari L, Richardson SL, Lynches T, Manetto V, Lanska DJ, Markesbery WR, Currier RD et al: Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 1995, 45:1062-1067. The third of an important triad of papers linking a specific region of chromosome 17 to atypical dementia, now with the twist that deposits of prion-specific protein and protease resistant prion-specific protein fragments were present despite an absence of any mutation involving the PrP gene on chromosome 20.
5. Ashworth A, Brown J, Gydesen S, Sorenson SA, Rossor MN, Hardy J, Collinge J: Frontal lobe or 'nonspecific' dementias are genetically heterogeneous. Neurology 1995, 45:1781. A brief correspondence reporting that familial dementia maps to chromosome 3.
6. Castellani R, Smith MA, Richey PL, Kalaria R, Gambetti P, Perry G: Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res 1995, 696:268-271. This supports the theory that free radical damage and oxidative stress may be pathogenetic factors in a wide variety of neurodegenerative diseases characterized by abnormal neurofilament accumulation.
7. Kesler A, Artzy T, Yaretzky A, Kott E: Slowly progressive aphasia, a left temporal variant of probable Pick's disease: 15 years of follow-up. Israel J Med Sci 1995, 31:626-628.
8. Miwa H, Sato S, Mori H, Mizuno Y: Unilateral basal ganglia involvement in primary progressive aphasia. J Neurol 1995, 242:350-351.
9. Arima K, Uesugi H, Fujita I, Sakurai Y, Oyanagi S, Andoh S, Izumiyama Y, Inose T: Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies. J Neurol Sci 1994, 127:186-197.
10. Doran M, Xuereb J, Hodges JR: Rapidly progressive aphasia with bulbar motor neurone disease: a clinical and neuropsychological study. Behav Neurol 1995, 8:169-180. Five more cases of rapidly progressive aphasia in patients with MND are reported, adding to the existing literature by further showing, in one patient, Alzheimer's type pathology in left perisylvian language cortices paralleling the clinical deficit and, in a second patient, cortical Lewy bodies, neither of which have been reported previously in this condition.
11. Fuh JL, Liao KK, Wang SJ, Lin KN: Swallowing difficulty in primary progressive aphasia: a case report. Cortex 1994, 30:701-705.
12. Trick GL, Trick LR, Morris P, Wolf M: Visual field loss in senile dementia of the Alzheimer's type. Neurology 1995, 45:68-74.
13. Lang AE, Maragonore D, Marsden CD, Tanner C: Movement Disorder Society Symposium on cortical-basal ganglionic degeneration (CBQD) and its relationship to other asymmetrical cortical degeneration syndromes. Mov Disord 1996, 11:346-357. A detailed and multi-authored discussion about the clinical and pathological features of CBGD and its relationship to other ACDS, concluding that despite clincial and pathological variability, sufficient consistency exists to warrant CBGD's designation as a distinct clinico-pathologic entity. The term PARAS was proposed to replace CBGD.
14. Feany MB, Ksiezak-Reding H, Liu WK, Vincent I, Yen SHC, Dickson DW: Epitope expression and hyperphosphorylation of tau protein in cortico-basal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 1995, 90:37-43. The authors provide evidence that the cytoskeletal abnormalities that occur in CBGD are unique and immunohistochemically and antigenically distinct from those which occur in Alzheimer's disease and PSP, lending further credence to the view that CBGD is a distinct nosologie disorder with a consistent pathological profile.
15. Jendroska K, Rossor MN, Mathias CJ, Daniel SE: Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord 1995, 10:111-114.
16. Green RC, Goldstein FC, Mirra SS, Alazraki NP, Baxt JL, Bakay RAE: Slowly progressive apraxia in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995, 59:312-315.
17. Ceccaldi M, Poncet M, Gambarelli D, Guinot H, Bille J: Progressive severity of left unilateral apraxia in 2 cases of Alzheimer's disease [In French]. Rev Neurol 1995, 151:240-246.
18. Caselli RJ, Reiman EM, Timmann D, Stelmach GE, Lawson MA, Osborne D, Moore SB, Cevette MJ: Progressive apraxia in clinically discordant monozygotic twins. Arch Neurol 1995, 52:1004-1010. A detailed case study of a clinically discordant twin pair showing that there are focal, homologous contralateral, and generalized degenerative components to this illness and that subclinical disease was present in the unaffected twin.
19. Pillon B, Blin J, Vidailhet M, Deweer B, Sirigu A, Dubois B, Agid Y: The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995, 45:1477-1483. Apraxia is asymmetric and most severe in CBGD. Memory was impaired in all three patients but semantic cueing helped CBGD and PSP patients much more than those with Alzheimer's disease.
20. Massman PJ, Kreitner KT, Jankovic J, Doody RS: Neuropsychological functioning in cortico-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology 1996, 46:720-726. Memory is less severe impaired and apraxia is more severe in patients with CBGD than in those with Alzheimer's disease.
21. Rapcsak SZ, Ochipa C, Anderson KC, Poizner H: Progressive ideomotor apraxia: evidence for a selective impairment of the action production system. Brain Cogn 1995, 27:213-236. A sophisticated kinematic analysis of apraxia.
22. Halliday GM, Davies L, McRitchie DA, Cartwright H, Pamphlett R, Morris JGL: Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol 1995, 90:66-75. The authors show frontal lobe involvement which may be important for the motor syndrome of CBGD.
23. Sodeyama N, Shimada M, Uchihara T, Yanagisawa K, Fujigasaki H, Yamaguchi K, Matsushita M, Yamada M: Spastic tetraplegia as an initial manifestation of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995, 59:395-399. The first time Alzheimer's pathology has been associated with a progressive spastic syndrome which evolved into a dementia with frontotemporal atrophy.
24. Boulan-Predseil P, Vital A, Brochet B, Darriet D, Henry P, Vital C: Dementia of frontal lobe type due to adult polyglucosan body disease. J Neurol 1995, 242:512-516. A previously unreported substrate for frontotemporal dementia.
25. Kiernan JA, Hudson AJ: Frontal lobe atrophy in motor neuron diseases. Brain 1994, 117:747-757.
26. Caselli RJ, Smith BE, Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurol 1996, 45:2005-2009. Nine patients fulfilling the Pringle criteria for PLS underwent detailed neuropsychological testing which showed problems reflecting frontal lobe function and memory.
27. Bruyn RPM, Koelman JHTM, Troost D, de Jong JMBV: Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry 1995, 58:742-744. This study bridges the gap between PLS and amyotrophic lateral sclerosis by showing three patients with a very slowly progressive course more typical of PLS, who developed lower motor neuron features of amyotrophic lateral sclerosis as much as 27 years later.
28. Talbot PR, Goulding PJ, Lloyd JJ, Snowden JS, Neary D, Testa HJ: Inter-relation between 'classic' motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995, 58:541-547. A timely study showing the frontal lobe component in classic motor neuron disease, suggesting it is part of a continuum that includes frontotemporal dementia, frontotemporal dementia and motor neuron disease complex, and uncomplicated MND.
29. Abrahams S, Goldstein LH, Lloyd CM, Brooks DJ, Leigh PN: Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation. J Neurol Sci 1995, 129(suppl):54-55.
30. Abrahams S, Leigh PN, Kew JJM, Goldstein LH, Lloyd CML, Brooks DJ: A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci 1995, 129(suppl):44-46.
31. Mochizuki Y, Mizutani T, Takasu T: Amyotrophic lateral sclerosis with marked neurological asymmetry: clinicopathological study. Acta Neuropathol 1995, 90:44-50. Interesting correlation of laterality of upper and lower motor neuron degeneration supporting a trans-synaptically mediated causative factor.
32. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. JAMA 1995, 273:1274-1278. An excellent population-based study correlating longitudinal neuropsychological data with apolipoprotein E status in patients with a progressive amnesic syndrome.
33. Convit A, de Leon MJ, Tarshish C, De Santi S, Kluger A, Rusinek H, George AE: Hippocampal volume losses in minimally impaired elderly [Letter]. Lancet 1995, i:266.
34. Evans JJ, Heggs AJ, Antoun N, Hodges JR: Progressive prosopagnosia associated with selective right temporal lobe atrophy; a new syndrome? Brain 1995, 118:1-13.
35. Takauchi S, Yamauchi S, Morimura Y, Ohara K, Morita Y, Hayashi S, Miyoshi K: Coexistence of Pick bodies and atypical Lewy bodies in the locus ceruleus neurons of Pick's disease, Acta Neuropathol 1995, 90:93-100.
36. Hedera P, Lerner AJ, Castellani R, Friedland RP: Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. J Neurol Sci 1995, 128:219-224.
37. Horoupian DS, Chu PL: Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles. Acta Neuropathol 1994, 88:592-598.
38. Hilton DA, Love S, Ferguson I, Newman P: Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient. Acta Neuropathol 1995, 90:101-106.
39. Mackenzie IRA, Hudson LP: Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol 1995, 90:615-619.
40. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG: Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol 1995, 89:275-283.
41. Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, Parker N, Kurth S, Horn SD: Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. Am J Neuroradiol 1995, 16:241-251. This type of analysis will probably gain in importance as quantitative structural imaging gains greater clinical prominence.
42. Talbot PR, Snowden JS, Lloyd JJ, Neary D, Testa H: The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol 1995, 242:579-586.